targeted

Annexon Highlights Pivotal Data on First Potential Targeted Therapy for Guillain-Barr Syndrome (GBS) and Showcases New GBS Education Campaign at American Academy of Neurology (AAN) 2025 Annual MeetingAnnexon Highlights Pivotal Data on First Potential Targeted Therapy for Guillain-Barr Syndrome (GBS) and Showcases New GBS Education Campaign at American Academy of Neurology (AAN) 2025 Annual Meeting

Annexon Highlights Pivotal Data on First Potential Targeted Therapy for Guillain-Barr Syndrome (GBS) and Showcases New GBS Education Campaign at American Academy of Neurology (AAN) 2025 Annual Meeting

April 08, 2025 16:05 ET  | Source: Annexon Biosciences Oral Presentation Features Phase 3 Data Showing Rapid Recovery and Durable…

2 weeks ago
Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug ConjugateRadiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate

Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate

BOSTON, Massachusetts, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc., ("Radiance" or the "Company"), a biotechnology company, today announced…

2 months ago